About 1 in 6 of Medicare patients report trouble paying Medicare bills and debt.
OCD is highly comorbid and warrants consideration in difficult to treat cases. Learn more here.
When concern for a patient is not so severe that a clinician feels compelled to call the police, there are options.
Amidst this world of unknowns, the authors share some tips and advice to weather the financial fallout of this storm.
How can we face the current pandemic while addressing the brain health crisis?
How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?
There are 4 crucial failings in our current health care system, where the importance of relationships is ignored.
How to help individuals caught in human trafficking: person-centered, culturally humble, trauma-informed care.
Concurrent treatments targeting eating disorders and PTSD are needed to help these patients with complex conditions.
Richard Jackson, MD, and Micheal Asbach, DMSc, PA-C, provide their key takeaways from these studies and insights on how providers can assess the impact of of tardive dyskinesia (TD) in every visit.
Social distancing and quarantine have been absolutely necessary, but what effect have they had on seniors?
Interventions that rely solely on change lack balance. This is especially true when working with minoritized individuals who have very real and justified pain stemming from systemic problems.
Research presented at the ACNP 2023 Annual Meeting shows that neuromodulation therapy cTBS could be a viable schizophrenia-specific intervention for nicotine use.
How can the women around us help us dream, grow, and serve?
Black mothers in the US experience far worse outcomes. Here’s what clinicians need to know.
Patients’ reports of medication adherence are sometimes inaccurate, but digital tools offer opportunities to collect objective data.
The Federal Trade Commission voted 3-2 to ban noncompete clauses between employers and workers, citing health care specifically among their reasons for supporting the ban.
All these events that occurred over the weekend bear social psychiatric weight.
Elena Koundourakis, the head of the Orexin Franchise Development and Portfolio Strategy at Takeda, shares her thoughts on the recent positive topline results from a phase 2 trial evaluating TAK-861, an oral orexin receptor 2 agonist, in patients with narcolepsy type 1.
There is absolutely no good reason for competition among therapies—none is by itself necessary or sufficient, and most are completely complementary, even synergistic.
How can we help to reduce the risk of burnout among nurse practitioners in psychiatry?
The 988 Implementation Act was introduced on July 25. What impact will it have on care?
Sanjai Rao, MD, DFAPA, and Kimberly Garcia, DNP, CRNP provide some advice to clinicians on explaining schizophrenia to patients and caregivers to achieve understanding and therapy adherence.
Has the media’s obsession with the COVID-19 pandemic put global mental health at risk?
Classic psychedelic research is rapidly expanding...
How can we bridge the gap between job-seekers in this community and inclusion-minded organizations?
Approximately 30 million individuals will be diagnosed with an eating disorder in the United States during their lifetime.
The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
Recovery from addiction does not protect against normal life events...
One doctor introduces the work of philosopher and critic Walter Benjamin and elements of his conceptualization of “experience.”